{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:48:00Z","timestamp":1792194480262,"version":"4.4.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>As people age with HIV (PWH), many comorbid diseases are more common than among age matched comparators without HIV (PWoH). While the Veterans Aging Cohort (VACS) Index 2.0 accurately predicts mortality in PWH using age and clinical biomarkers, the only included comorbidity is hepatitis C. We asked whether adding comorbid disease groupings from the Charlson Comorbidity Index (CCI) improves the accuracy of VACS Index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To maximize our ability to model mortality among older age groups, we began with PWoH in Veterans Health Administration (VA) from 2007\u20132017, divided into development and validation samples. Baseline predictors included age, and components of CCI and VACS Index (excluding CD4 count and HIV RNA). Patients were followed until December 31, 2021. We used Cox models to develop the VACS-CCI score and estimated mortality using a parametric (gamma) survival model. We compared accuracy using C-statistics and calibration curves in validation overall and within subgroups (gender, age &amp;lt;\/\u226565 years, race\/ethnicity, and CCI score). We then applied VACS-CCI in PWH and compared its accuracy to age, VACS Index 2.0, CCI and VACS-CCI with CD4 and HIV RNA added.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analytic sample consisted of 6,588,688 PWoH and 30,539 PWH. Among PWoH\/PWH, median age was 65\/55 years; 6%\/3% were women; 15%\/48% were Black and 5%\/7% Hispanic. VACS-CCI provided the best discrimination (C-statistic\u2009=\u20090.81) with excellent calibration (predicted and observed mortality largely overlapped) overall and within subgroups. When VACS-CCI was applied to PWH it demonstrated similar discrimination as VACS Index 2.0 (C-statistic\u2009=\u20090.77 for both) but superior calibration among those with CD4\u2009&amp;lt;\u2009200. Discrimination was improved when CD4 and HIV RNA were added VACS-CCI (C-statistic\u2009=\u20090.79). Liver and kidney disease, congestive heart failure, malignancy, and dementia were negatively associated with CD4 (<jats:italic>p<\/jats:italic>-trends all &amp;lt;0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Among PWH and PWoH in VA care, age alone weakly discriminates risk of mortality. VACS Index 2.0, CCI, and VACS-CCI all provide better discrimination, but VACS-CCI is more consistently calibrated. The association of comorbid diseases with lower CD4 underscores the likely role of HIV in non-AIDS conditions. Future work will include adding CD4 and HIV RNA to VACS-CCI and validating it in independent data.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1342466","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T04:43:14Z","timestamp":1706676194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration"],"prefix":"10.3389","volume":"10","author":[{"given":"Kathleen A.","family":"McGinnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Rodriguez-Barradas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisann K.","family":"Oursler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall J.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet P.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Veterans Aging Cohort Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/cid\/ciu869","article-title":"Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults","volume":"60","author":"Althoff","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with human immunodeficiency virus in the United States","volume":"66","author":"Wong","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2352-3018(17)30029-2","article-title":"Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study. The measurement of health adjusted life expectancy (HALE) on a population-based observational cohort of HIV-positive and negative men and women in British Columbia","volume":"4","author":"Hogg","year":"2017","journal-title":"Lancet HIV"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7326\/M16-2094","article-title":"Association of Viral Suppression with Lower AIDS-defining and non-AIDS-defining Cancer incidence in HIV-infected veterans: a prospective cohort study","volume":"169","author":"Park","year":"2018","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/aje\/kwz232","article-title":"Life-expectancy disparities among adults with HIV in the United States and Canada: the impact of a reduction in drug- and alcohol-related deaths using the lives saved simulation model","volume":"188","author":"Althoff","year":"2019","journal-title":"Am J Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1468-1293.2009.00757.x","article-title":"Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers","volume":"11","author":"Justice","year":"2010","journal-title":"HIV Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","article-title":"Veterans aging cohort S, the antiretroviral therapy cohort C. Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals","volume":"33","author":"Tate","year":"2019","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/cid\/ciab883","article-title":"Discrimination and calibration of the veterans aging cohort study index 2.0 for predicting mortality among people with human immunodeficiency virus in North America","volume":"75","author":"McGinnis","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0b013e318278f3fa","article-title":"Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected veterans","volume":"62","author":"Akgun","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cid\/ciw564","article-title":"Baseline, time-updated, and cumulative HIV care metrics for predicting acute myocardial infarction and all-cause mortality","volume":"63","author":"Salinas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/cid\/cit056","article-title":"Physiologic frailty and fragility fracture in HIV-infected male veterans","volume":"56","author":"Womack","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/cid\/ciw328","article-title":"The veterans aging cohort study (VACS) index and neurocognitive change: a longitudinal study","volume":"63","author":"Marquine","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/QAI.0000000000000008","article-title":"The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment","volume":"65","author":"Marquine","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the veterans aging cohort study index for mortality with HIV infection: a north American cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2016.01.017","article-title":"Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men","volume":"161","author":"Justice","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a \"virtual\" cohort using the national VA health information system","volume":"44","author":"Fultz","year":"2006","journal-title":"Med Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metrics"},{"key":"ref19","author":"Maynard","year":"2021"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/QAI.0000000000000341","article-title":"An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals","volume":"67","author":"Akgun","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"ref25","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/pds.5204","article-title":"Validation of an international classification of disease, 10th revision coding adaptation for the Charlson comorbidity index in United States healthcare claims data","volume":"30","author":"Beyrer","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/jgs.18265","article-title":"Delirium among people aging with and without HIV: role of alcohol and Neurocognitively active medications","volume":"71","author":"Akgun","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0241825","DOI":"10.1371\/journal.pone.0241825","article-title":"Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: the veterans health administration COVID-19 (VACO) index","volume":"15","author":"King","year":"2020","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/QAI.0000000000002049","article-title":"HIV disease severity is sensitive to temporal changes in alcohol use: a National Study of VA patients with HIV","volume":"81","author":"Williams","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/jamia\/ocac065","article-title":"A bias evaluation checklist for predictive models and its pilot application for 30-day hospital readmission models","volume":"29","author":"Wang","year":"2022","journal-title":"J Am Med Inform Assoc"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.3389\/fmed.2024.1532350","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1342466\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:22:51Z","timestamp":1736266971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1342466\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":31,"alternative-id":["10.3389\/fmed.2023.1342466"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1342466","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fmed.2024.1532350","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"1342466"}}